Table 2. Proportion of patients who progress to death at each treatment line.

	Proportion of patients dying
Treatment line	Cohort A (with fulvestrant)	Cohort B (without fulvestrant)
1	0.19	0.19
2	0.23	0.23
3	0.28	0.28
4	0.35	0.35
5	0.5	1.0
6	1.0	—

Source: UK clinicians survey.